Amelioration of dextran sodium sulfate-induced colitis in mice by rhodobacter sphaeroides extract

Molecules

Volumn 17, Issue 11, 2012, Pages 13622-13630

  Liu, Wen Sheng ^a,b   Chen, Man Chin ^c   Chiu, Kuo Hsun ^d   Wen, Zhi Hong ^a   Lee, Che Hsin ^c  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b Asia Pacific Biotech Developing Inc   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

Author keywords

Colitis; Dextran sodium sulfate; Inflammatory; Lycogen ; Rhodobacter sphaeroides

Indexed keywords

ANTIINFLAMMATORY AGENT; CAROTENOID; DEXTRAN SULFATE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COLITIS; COLON; DRUG EFFECT; FEMALE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUSE; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PATHOLOGY; RHODOBACTER SPHAEROIDES; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; CAROTENOIDS; COLITIS; COLON; DEXTRAN SULFATE; FEMALE; INTERLEUKIN-1BETA; MICE; MICE, INBRED BALB C; ORGAN SIZE; RHODOBACTER SPHAEROIDES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 84870191666     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules171113622     Document Type: Article

References (24)

1. Strober, W.; James, S.P. The immunologic basis of inflammatory bowel disease. J. Clin. Immunol. 1986, 6, 415-432.
2. Sands, B.E. Therapy of inflammatory bowel disease. Gastroenterology 2000, 118, S68-S82.
3. Blam, M.E.; Stein, R.B.; Lichtenstein, G.R. Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: Current and future perspectives. Am. J. Gastroenterol. 2001, 96, 1977-1997.
4. Wu, S.L.; Chen, J.C.; Li, C.C.; Lo, H.Y.; Ho, T.Y.; Hsiang, C.Y. Vanillin improves and prevents trinitrobenzene sulfonic acid-induced colitis in mice. J. Pharmacol. Exp. Ther. 2009, 330, 370-376.
5. Hsiang, C.Y.; Lo, H.Y.; Huang, H.C.; Li, C.C.; Wu, S.L.; Ho, T.Y. Ginger extract and zingerone ameliorated trinitrobenzene sulphonic acid-induced colitis in mice via modulation of nuclear factor-κB activity and interleukin-1β signaling pathway. Food Chem. 2013, 136, 170-177.
6. Hanauer, S.B. Evolving concepts in treatment and disease modification in ulcerative colitis. Aliment. Pharmacol. Ther. 2008, 27, 15-21.
7. Langmead, L.; Rampton, D.S. Complementary and alternative therapies for inflammatory bowel disease. Aliment. Pharmacol. Ther. 2006, 23, 341-349.
8. Maher, M.M. Inflammatory bowel disease: Review and future view. Front. Biosci. 2012, 4, 1638-1647.
9. Jonkers, D.; Penders, J.; Masclee, A.; Pierik, M. Probiotics in the management of inflammatory bowel disease: A systematic review of intervention studies in adult patients. Drugs 2012, 72, 803-823.
10. Chen, Y.; Graham, A.; Potter, W.; Morgan, J.; Vaughan, L.; Bellnier, D.A.; Henderson, B.W.; Oseroff, A.; Dougherty, T.J.; Pandey, R.K. Bacteriopurpurinimides: Highly stable and potent photosensitizers for photodynamic therapy. J. Med. Chem. 2002, 45, 255-258.
11. Deshmukh, S.S.; Tang. K.; Kálmán, L. Lipid binding to the carotenoid binding site in photosynthetic reaction centers. J. Am. Chem. Soc. 2011, 133, 16309-16316.
12. Kelsey, L.; Katoch, P.; Johnson, K.E.; Batra, S.K.; Mehta, P.P. Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. PLoS One 2012, 7, e32846.
13. Chiou, Y.S.; Ma, N.J.; Sang, S.; Ho, C.T.; Wang, Y.J.; Pan, M.H. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. J. Agric. Food Chem. 2012, 60, 3441-3451.
14. Guarner, F. Prebiotics in inflammatory bowel diseases. Br. J. Nutr. 2007, 98, S85-S89.
15. Okamoto, K.; Fujiya, M.; Nata, T.; Ueno, N.; Inaba, Y.; Ishikawa, C.; Ito, T.; Moriichi, K.; Tanabe, H.; Mizukami, Y.; et al. Competence and sporulation factor derived from Bacillus subtilis improves epithelial cell injury in intestinal inflammation via immunomodulation and cytoprotection. Int. J. Colorectal. Dis. 2012, 27, 1039-1046.
16. Wu, W.T.; Liu, W.S. Anti-inflammstory property of biomaterial carotenoids production by Rhodobacter sphaeroidese WL-APD911. Adv. Mater. Res. 2011, 287-290, 2028-2031.
17. Umehara, Y.; Kudo, M.; Nakaoka, R.; Kawasaki, T.; Shiomi, M. Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis. Hepatogastroenterology 2006, 53, 879-882.
18. Cavaglieri, C.R.; Nishiyama, A.; Fernandes, L.C.; Curi, R.; Miles, E.A.; Calder, P.C. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 2003, 73, 1683-1690.
19. Russo, I.; Luciani, A.; de Cicco, P.; Troncone, E.; Ciacci, C. Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. PLoS One 2012, 7, e32841.
20. Albrecht, M.; Klein, A.; Hugueney, P.; Sandmann, G.; Kuntz, M. Molecular cloning and functional expression in E. coli of a novel plant enzyme mediating zeta-carotene desaturation. FEBS Lett. 1995, 372, 199-202.
21. Ghavipour, M.; Saedisomeolia, A.; Djalali, M.; Sotoudeh, G.; Eshraghyan, M.R.; Malekshahi, M.A.; Wood, L.G. Tomato juice consumption reduces systemic inflammation in overweight and obese females. Br. J. Nutr. 2012, 15, 1-5.
22. Sandmann, G.; Kuhn, S.; Böger, P. Evaluation of structurally different carotenoids in Escherichia coli transformants as protectants against UV-B radiation. Appl. Environ. Microbiol. 1998, 64, 1972-1974.
23. Okayasu, I.; Hatakeyama, S.; Yamada, M.; Ohkusa, T.; Inagaki, Y.; Nakaya, R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98, 694-702.
24. Cooper, H.S.; Murthy, S.N.; Shah, R.S.; Sedergran, D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993, 69, 238-249.